Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
08/28/2012 | US8252739 Albumin fusion proteins |
08/28/2012 | US8252738 Method for changing cell phenotype using LIM mineralization proteins |
08/28/2012 | US8252737 Antimicrobial peptides and methods of use |
08/28/2012 | US8252588 Stem cells having increased sensitivity to SDF-1 and methods of generating and using same |
08/28/2012 | US8252552 and processing of transgenic sugarcane for the recovery of high value proteins; using a nucleic acid encoding the promoter of a sugarcane proline rich protein |
08/28/2012 | US8252547 In vitro control of protein synthesis in mammalian cells by IP3 receptor-binding protein |
08/28/2012 | US8252545 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
08/28/2012 | US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
08/28/2012 | US8252520 Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases |
08/28/2012 | US8252340 Extract for treating thrombotic diseases |
08/28/2012 | US8252338 Synthetic LDL as targeted drug delivery vehicle |
08/28/2012 | US8252323 Compositions for mucosal delivery of agents |
08/28/2012 | US8252322 Delivery system with increased bioavailability |
08/28/2012 | US8252313 Controlling the amount of iodine a cat eats to restore norman thyroid function |
08/28/2012 | US8252309 Dietary supplement energy-providing to skeletal muscles |
08/28/2012 | US8252302 Methods and compositions to treat hemorrhagic conditions of the brain |
08/28/2012 | US8252291 Bacteriocins and novel bacterial strains |
08/28/2012 | US8252288 Methods of using multimeric complexes of antigens and an adjuvant |
08/28/2012 | US8252282 Nuclear telomerase reverse transcriptase variant |
08/28/2012 | US8252281 Methods for the treatment of sepsis and sepsis-associated cardiac dysfunction |
08/28/2012 | CA2639700C New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
08/28/2012 | CA2561588C Pressure sore treatment |
08/28/2012 | CA2553955C Acid alpha-glucosidase and fragments thereof |
08/28/2012 | CA2533846C Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer |
08/28/2012 | CA2520515C S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment |
08/28/2012 | CA2492470C Stable pharmaceutical composition comprising erythropoietin |
08/28/2012 | CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels |
08/28/2012 | CA2467383C Rapidly maturing fluorescent proteins and methods for using the same |
08/28/2012 | CA2454073C Mutations in ion channels |
08/28/2012 | CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
08/28/2012 | CA2445578C Biological pacemaker comprising dominant-negative kir2.1aaa |
08/28/2012 | CA2432978C Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
08/28/2012 | CA2412531C Antimicrobial peptides and methods of use thereof |
08/28/2012 | CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
08/28/2012 | CA2395589C Method for removing multimers of human serum albumin |
08/28/2012 | CA2389345C Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
08/28/2012 | CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof |
08/28/2012 | CA2284110C An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
08/23/2012 | WO2012112869A2 Targeted cancer therapy using ets transcriptional inhibitors |
08/23/2012 | WO2012112791A1 Radiation countermeasure agents |
08/23/2012 | WO2012112767A2 Collagen-targeted nanoparticles |
08/23/2012 | WO2012112690A2 Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains |
08/23/2012 | WO2012112681A1 Methods for treating lysosomal acid lipase deficiency |
08/23/2012 | WO2012112677A2 Methods for treating lysosomal acid lipase deficiency |
08/23/2012 | WO2012112626A2 Compositions, devices and methods of use thereof for the treatment of cancers |
08/23/2012 | WO2012112528A1 Use of mdl-1 antagonists to treat spondylarthropathy |
08/23/2012 | WO2012112489A2 Compositions and methods for the therapy and diagnosis of influenza |
08/23/2012 | WO2012112438A2 Anti-microbial agents and compositions and methods of production and use thereof |
08/23/2012 | WO2012112434A1 Inhibiting aberrant blood vessel formation using retargeted endopeptidases |
08/23/2012 | WO2012112432A1 Methods of inhibiting aberrant blood vessel formation using opioid retargeted endopeptidases |
08/23/2012 | WO2012112426A1 Arginine vasopressin retargeted clostridial endopeptidases for use in treating benign prostatic hyperplasia |
08/23/2012 | WO2012112422A1 Inhibiting aberrant blood vessel formation using growth factor retargeted endopeptidases |
08/23/2012 | WO2012112420A1 Treatments using psma ligand endopeptidases |
08/23/2012 | WO2012112319A1 Orally bioavailable peptide drug compositions and methods thereof |
08/23/2012 | WO2012112188A1 Hsa-related compositions and methods of use |
08/23/2012 | WO2012112007A2 Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock |
08/23/2012 | WO2012111900A1 Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mrna |
08/23/2012 | WO2012111878A1 Pharmaceutical composition containing the superoxide dismutase fusion protein for preventing or treating eye diseases |
08/23/2012 | WO2012111877A1 Eye drop composition containing a fusion protein for the fk506 binding protein for preventing or treating eye diseases |
08/23/2012 | WO2012111852A1 Therapeutic agent for vertebral body fracture and method for evaluating same |
08/23/2012 | WO2012110886A1 Controlled-release formulation comprising hcg |
08/23/2012 | WO2012110625A1 Wild-type apolipoprotein l-i for use in the prevention of kidney diseases |
08/23/2012 | WO2012110422A1 Long-acting il-1 receptor antagonists |
08/23/2012 | WO2012110249A1 Haprolid and derivatives thereof as inhibitors of hcv |
08/23/2012 | WO2012110200A1 Cyclic peptide cyclo (l -arginyl - glycyl - l -aspartyl - d - phenylalanyl - n-methyl - l -valyl), compositions thereof, and use thereof in methods for treating graft -versus - host disease |
08/23/2012 | WO2012109975A1 Pegylated analogue protein of canine urate oxidase, preparation method and use thereof |
08/23/2012 | WO2012109743A1 Methods and compositions relating to coagulation assays |
08/23/2012 | WO2012091278A3 Nanoemulsion-type ophthalmic composition |
08/23/2012 | WO2012090006A3 Methods for improving fracture healing and bone formation |
08/23/2012 | WO2012088388A9 Treating multiple myeloma |
08/23/2012 | WO2012088157A3 Glp-1 receptor agonists for islet cell transplantation |
08/23/2012 | WO2012072692A3 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis |
08/23/2012 | WO2012064181A8 A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof |
08/23/2012 | WO2012064146A3 Anticancer composition containing gkn 1 |
08/23/2012 | WO2012061015A3 L-citrulline supplementation during arginine depletion therapy with arginase |
08/23/2012 | WO2012060607A3 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same |
08/23/2012 | WO2012054792A3 Composition and method for immunological treatment of cancer, prevention of cancer recurrence and metastasis, and overcoming immune suppressor cells |
08/23/2012 | WO2012053827A3 Composition containing peptide ligand bonding with cxcr2 for treating infective and inflammatory diseases |
08/23/2012 | WO2012039954A3 Reliable stabilization of n-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns |
08/23/2012 | WO2012026712A4 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof |
08/23/2012 | WO2012006384A9 Rothia species gluten-degrading enzymes and uses thereof |
08/23/2012 | WO2011095768A8 Lantibiotic salts |
08/23/2012 | WO2011061561A3 Method of obtaining regenerative molecular matrices and regenerative molecular matrices thus obtained |
08/23/2012 | US20120216303 Novel therapeutic uses of human formyl peptide receptor antagonists |
08/23/2012 | US20120216302 Methods and assays for treating subjects with shank3 deletion, mutation or reduced expression |
08/23/2012 | US20120214967 Cross-linked glycopeptide-cephalosporin antibiotics |
08/23/2012 | US20120214866 Treatment with cytokines |
08/23/2012 | US20120214865 Methods for slowing familial als disease progression |
08/23/2012 | US20120214757 Methods and Compositions for Treating Cancer Using Proteasome Inhibitors |
08/23/2012 | US20120214750 Crystalline form of linaclotide |
08/23/2012 | US20120214749 Microparticles comprising somatostatin analogues |
08/23/2012 | US20120214748 Novel peptides, process for preparation thereof, and use thereof |
08/23/2012 | US20120214747 Recombinant human alpha1- antitrypsin |
08/23/2012 | US20120214746 Use of a composition comprising a non-fermented rice peptide hydrolyzate for stimulating hair growth |
08/23/2012 | US20120214745 Deuterated Cyclosporine Analogs and Methods of Making the Same |
08/23/2012 | US20120214744 Polypeptides and nucleic acids for treating erbb2-dependent cancers |
08/23/2012 | US20120214743 Itch suppressant |
08/23/2012 | US20120214742 Gaba release-regulating agent in cerebellum |
08/23/2012 | US20120214741 Vdac1 compositions and methods of use thereof for regulating apoptosis |
08/23/2012 | US20120214740 Medicinal Compositions Containing Highly Functionalized Chimeric Protein |